• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

聚合物纳米颗粒的摄取和转染取决于聚合物端基结构,但在很大程度上与纳米颗粒的物理化学性质无关。

Uptake and transfection with polymeric nanoparticles are dependent on polymer end-group structure, but largely independent of nanoparticle physical and chemical properties.

机构信息

Department of Biomedical Engineering, Johns Hopkins University School of Medicine, Baltimore, Maryland 21231, United States.

出版信息

Mol Pharm. 2012 Nov 5;9(11):3375-83. doi: 10.1021/mp3004176. Epub 2012 Sep 27.

DOI:10.1021/mp3004176
PMID:22970908
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3779641/
Abstract

Development of nonviral particles for gene delivery requires a greater understanding of the properties that enable gene delivery particles to overcome the numerous barriers to intracellular DNA delivery. Linear poly(beta-amino) esters (PBAE) have shown substantial promise for gene delivery, but the mechanism behind their effectiveness is not well quantified with respect to these barriers. In this study, we synthesized, characterized, and evaluated for gene delivery an array of linear PBAEs that differed by small changes along the backbone, side chain, and end group of the polymers. We examined particle size and surface charge, polymer molecular weight, polymer degradation rate, buffering capacity, cellular uptake, transfection, and cytotoxicity of nanoparticles formulated with these polymers. Significantly, this is the first study that has quantified how small differential structural changes to polymers of this class modulate buffering capacity and polymer degradation rate and relates these findings to gene delivery efficacy. All polymers formed positively charged (zeta potential 21-29 mV) nanosized particles (∼150 nm). The polymers hydrolytically degraded quickly in physiological conditions, with half-lives ranging from 90 min to 6 h depending on polymer structure. The PBAE buffering capacities in the relevant pH range (pH 5.1-7.4) varied from 34% to 95% protonatable amines, and on a per mass basis, PBAEs buffered 1.4-4.6 mmol of H(+)/g. When compared to 25 kDa branched polyethyleneimine (PEI), PBAEs buffer significantly fewer protons/mass, as PEI buffers 6.2 mmol of H(+)/g over the same range. However, due to the relatively low cytotoxicity of PBAEs, higher polymer mass can be used to form particles than with PEI and total buffering capacity of PBAE-based particles significantly exceeds that of PEI. Uptake into COS-7 cells ranged from 0% to 95% of cells and transfection ranged from 0% to 93% of cells, depending on the base polymer structure and the end modifications examined. Five polymers achieved higher uptake and transfection efficacy with less toxicity than branched-PEI control. Surprisingly, acrylate-terminated base polymers were dramatically less efficacious than their end-capped versions, in terms of both uptake (1-3% for acrylate, 75-94% for end-capped) and transfection efficacy (0-1% vs 20-89%), even though there are minimal differences between acrylate and end-capped polymers in terms of DNA retardation in gel electrophoresis, particle size, zeta potential, and cytotoxicity. These studies further elucidate the role of polymer structure for gene delivery and highlight that small molecule end-group modification of a linear polymer can be critical for cellular uptake in a manner that is largely independent of polymer/DNA binding, particle size, and particle surface charge.

摘要

为了实现基因传递,需要开发非病毒颗粒,这就要求我们更深入地了解使基因传递颗粒能够克服细胞内 DNA 传递的众多障碍的特性。线性聚(β-氨基酯)(PBAE)在基因传递方面显示出巨大的应用前景,但它们的有效性机制在很大程度上尚未针对这些障碍进行量化。在这项研究中,我们合成、表征并评估了一系列线性 PBAE,这些 PBAE 在聚合物主链、侧链和端基上发生了微小的变化。我们研究了这些聚合物形成的纳米颗粒的粒径和表面电荷、聚合物分子量、聚合物降解率、缓冲能力、细胞摄取、转染和细胞毒性。重要的是,这是第一项定量研究此类聚合物的微小结构变化如何调节缓冲能力和聚合物降解率,并将这些发现与基因传递效率联系起来的研究。所有聚合物都形成带正电的(ζ电位 21-29 mV)纳米颗粒(约 150nm)。聚合物在生理条件下迅速发生水解降解,半衰期根据聚合物结构的不同而在 90 分钟至 6 小时之间。在相关的 pH 范围(pH 5.1-7.4)内,PBAE 的缓冲能力为 34%-95%可质子化的胺,并且按质量计,PBAE 缓冲 1.4-4.6mmol 的 H(+)/g。与 25kDa 支化聚乙烯亚胺(PEI)相比,PBAE 缓冲质子的数量要少得多,因为在相同范围内,PEI 缓冲 6.2mmol 的 H(+)/g。然而,由于 PBAE 的相对低细胞毒性,可以使用比 PEI 更高的聚合物质量来形成颗粒,并且 PBAE 基颗粒的总缓冲能力大大超过 PEI。COS-7 细胞的摄取率在 0%-95%之间,转染率在 0%-93%之间,具体取决于基础聚合物结构和所研究的末端修饰。与支化-PEI 对照相比,五种聚合物的毒性更低,摄取和转染效率更高。令人惊讶的是,与端封版本相比,末端封端的丙烯酸酯基聚合物在摄取(丙烯酸酯为 1-3%,端封端为 75-94%)和转染效率(0-1%对 20-89%)方面的效率都明显降低,尽管在凝胶电泳中 DNA 阻滞、粒径、ζ 电位和细胞毒性方面,丙烯酸酯和端封聚合物之间几乎没有差异。这些研究进一步阐明了聚合物结构在基因传递中的作用,并强调了线性聚合物小分子端基修饰对于细胞摄取的重要性,这种方式在很大程度上独立于聚合物/DNA 结合、颗粒大小和颗粒表面电荷。

相似文献

1
Uptake and transfection with polymeric nanoparticles are dependent on polymer end-group structure, but largely independent of nanoparticle physical and chemical properties.聚合物纳米颗粒的摄取和转染取决于聚合物端基结构,但在很大程度上与纳米颗粒的物理化学性质无关。
Mol Pharm. 2012 Nov 5;9(11):3375-83. doi: 10.1021/mp3004176. Epub 2012 Sep 27.
2
A combinatorial polymer library approach yields insight into nonviral gene delivery.组合聚合物文库方法为非病毒基因传递提供了深入了解。
Acc Chem Res. 2008 Jun;41(6):749-59. doi: 10.1021/ar7002336.
3
Differential polymer structure tunes mechanism of cellular uptake and transfection routes of poly(β-amino ester) polyplexes in human breast cancer cells.不同的聚合物结构调节聚(β-氨基酯)多聚体在人乳腺癌细胞中的细胞摄取机制和转染途径。
Bioconjug Chem. 2014 Jan 15;25(1):43-51. doi: 10.1021/bc4002322. Epub 2013 Dec 20.
4
Synthesis and application of poly(ethylene glycol)-co-poly(β-amino ester) copolymers for small cell lung cancer gene therapy.用于小细胞肺癌基因治疗的聚(乙二醇)-共-聚(β-氨基酯)共聚物的合成与应用
Acta Biomater. 2016 Sep 1;41:293-301. doi: 10.1016/j.actbio.2016.05.040. Epub 2016 Jun 1.
5
Engineered polyallylamine nanoparticles for efficient in vitro transfection.用于高效体外转染的工程化聚烯丙胺纳米颗粒。
Pharm Res. 2007 Aug;24(8):1427-40. doi: 10.1007/s11095-007-9259-7. Epub 2007 Mar 24.
6
Surface modified poly(β amino ester)-containing nanoparticles for plasmid DNA delivery.表面修饰的含聚(β 氨基酸酯)纳米粒用于质粒 DNA 的递送。
J Control Release. 2012 Nov 28;164(1):41-8. doi: 10.1016/j.jconrel.2012.09.020. Epub 2012 Oct 5.
7
Poly(β-amino ester)-nanoparticle mediated transfection of retinal pigment epithelial cells in vitro and in vivo.聚(β-氨基酯)-纳米颗粒介导的视网膜色素上皮细胞的体外和体内转染。
PLoS One. 2012;7(5):e37543. doi: 10.1371/journal.pone.0037543. Epub 2012 May 21.
8
Efficiency of Cytosolic Delivery with Poly(β-amino ester) Nanoparticles is Dependent on the Effective p of the Polymer.聚(β-氨基酯)纳米颗粒的胞质递送效率取决于聚合物的有效p值。
ACS Biomater Sci Eng. 2020 Jun 8;6(6):3411-3421. doi: 10.1021/acsbiomaterials.0c00271. Epub 2020 May 18.
9
Biscarbamate cross-linked polyethylenimine derivative with low molecular weight, low cytotoxicity, and high efficiency for gene delivery.低分子量、低细胞毒性、高效的双氨基甲酸酯交联聚乙烯亚胺衍生物用于基因传递。
Int J Nanomedicine. 2012;7:693-704. doi: 10.2147/IJN.S27849. Epub 2012 Feb 9.
10
Poly(ethylene oxide) grafted with short polyethylenimine gives DNA polyplexes with superior colloidal stability, low cytotoxicity, and potent in vitro gene transfection under serum conditions.聚乙二醇接枝短链聚乙烯亚胺赋予 DNA 多聚物优越的胶体稳定性、低细胞毒性,并在血清条件下具有强大的体外基因转染能力。
Biomacromolecules. 2012 Mar 12;13(3):881-8. doi: 10.1021/bm2017965. Epub 2012 Feb 27.

引用本文的文献

1
Synthesis, characterization, and evaluation of low molecular weight poly(β-amino ester) nanocarriers for enhanced T cell transfection and gene delivery in cancer immunotherapy.用于癌症免疫治疗中增强T细胞转染和基因递送的低分子量聚(β-氨基酯)纳米载体的合成、表征及评估
Nanoscale Adv. 2025 May 2. doi: 10.1039/d5na00169b.
2
Exploring Advanced CRISPR Delivery Technologies for Therapeutic Genome Editing.探索用于治疗性基因组编辑的先进CRISPR递送技术。
Small Sci. 2024 Jul 25;4(10):2400192. doi: 10.1002/smsc.202400192. eCollection 2024 Oct.
3
Suprachoroidal Delivery of Viral and Nonviral Vectors for Treatment of Retinal and Choroidal Vascular Diseases.

本文引用的文献

1
Small-Molecule End-Groups of Linear Polymer Determine Cell-type Gene-Delivery Efficacy.线性聚合物的小分子端基决定细胞类型基因传递效率。
Adv Mater. 2009 Dec 28;21(48):4947-4951. doi: 10.1002/adma.200901718. Epub 2009 Aug 15.
2
Advances in polymeric and inorganic vectors for nonviral nucleic acid delivery.用于非病毒核酸递送的聚合物和无机载体的进展。
Ther Deliv. 2011 Apr;2(4):493-521. doi: 10.4155/tde.11.14.
3
Poly(β-amino ester)-nanoparticle mediated transfection of retinal pigment epithelial cells in vitro and in vivo.聚(β-氨基酯)-纳米颗粒介导的视网膜色素上皮细胞的体外和体内转染。
用于治疗视网膜和脉络膜血管疾病的病毒和非病毒载体的脉络膜上腔递送
Am J Ophthalmol. 2024 Dec 21. doi: 10.1016/j.ajo.2024.12.010.
4
Polymeric Vehicles for Nucleic Acid Delivery: Enhancing the Therapeutic Efficacy and Cellular Uptake.聚合物载体用于核酸递送:增强治疗效果和细胞摄取。
Recent Adv Drug Deliv Formul. 2024;18(4):276-293. doi: 10.2174/0126673878324536240805060143.
5
Ligand-free biodegradable poly(beta-amino ester) nanoparticles for targeted systemic delivery of mRNA to the lungs.无配体可生物降解的聚(β-氨基酯)纳米粒用于靶向递送至肺部的 mRNA 的系统给药。
Biomaterials. 2025 Feb;313:122753. doi: 10.1016/j.biomaterials.2024.122753. Epub 2024 Aug 20.
6
RNA therapeutics in targeting G protein-coupled receptors: Recent advances and challenges.靶向G蛋白偶联受体的RNA疗法:最新进展与挑战
Mol Ther Nucleic Acids. 2024 Apr 24;35(2):102195. doi: 10.1016/j.omtn.2024.102195. eCollection 2024 Jun 11.
7
Suprachoroidal gene transfer with nonviral nanoparticles in large animal eyes.大动物眼中的脉络膜上腔基因传递与非病毒纳米颗粒
Sci Adv. 2024 Mar 8;10(10):eadl3576. doi: 10.1126/sciadv.adl3576.
8
Charge neutralized poly(β-amino ester) polyplex nanoparticles for delivery of self-amplifying RNA.用于递送自扩增RNA的电荷中和型聚(β-氨基酯)多聚体纳米颗粒
Nanoscale Adv. 2024 Jan 24;6(5):1409-1422. doi: 10.1039/d3na00794d. eCollection 2024 Feb 27.
9
mRNA Vaccine Nanoplatforms and Innate Immunity.mRNA 疫苗纳米平台与固有免疫。
Viruses. 2024 Jan 14;16(1):120. doi: 10.3390/v16010120.
10
Net anionic poly(β-amino ester)s: synthesis, pH-dependent behavior, and complexation with cationic cargo.净阴离子聚(β-氨基酯):合成、pH 依赖性行为以及与阳离子货物的络合作用
Polym Chem. 2023 Jan 28;14(4):421-431. doi: 10.1039/d2py01319c. Epub 2022 Dec 21.
PLoS One. 2012;7(5):e37543. doi: 10.1371/journal.pone.0037543. Epub 2012 May 21.
4
2011 Rita Schaffer lecture: nanoparticles for intracellular nucleic acid delivery.2011 年丽塔·谢弗讲座:用于细胞内核酸递送的纳米颗粒。
Ann Biomed Eng. 2012 Jul;40(7):1408-18. doi: 10.1007/s10439-012-0550-3. Epub 2012 Mar 27.
5
Effect of molecular weight of amine end-modified poly(β-amino ester)s on gene delivery efficiency and toxicity.胺封端的聚(β-氨基酯)的分子量对基因传递效率和毒性的影响。
Biomaterials. 2012 May;33(13):3594-603. doi: 10.1016/j.biomaterials.2012.01.046. Epub 2012 Feb 14.
6
Synthetic poly(ester amine) and poly(amido amine) nanoparticles for efficient DNA and siRNA delivery to human endothelial cells.用于向人内皮细胞高效递送 DNA 和 siRNA 的合成聚酯胺和聚酰胺-胺纳米粒子。
Int J Nanomedicine. 2011;6:3309-22. doi: 10.2147/IJN.S27269. Epub 2011 Dec 13.
7
A novel assay for quantifying the number of plasmids encapsulated by polymer nanoparticles.一种用于定量测定聚合物纳米颗粒包裹的质粒数量的新方法。
Small. 2012 Feb 6;8(3):367-73. doi: 10.1002/smll.201101718. Epub 2011 Dec 5.
8
Biodegradable poly(amine-co-ester) terpolymers for targeted gene delivery.用于靶向基因传递的可生物降解的聚(胺-酯)三元共聚物。
Nat Mater. 2011 Dec 4;11(1):82-90. doi: 10.1038/nmat3187.
9
Effects of base polymer hydrophobicity and end-group modification on polymeric gene delivery.聚合物基因递送中基底聚合物疏水性和端基修饰的影响。
Biomacromolecules. 2011 Oct 10;12(10):3592-600. doi: 10.1021/bm200807s. Epub 2011 Sep 9.
10
HPMA-oligolysine copolymers for gene delivery: optimization of peptide length and polymer molecular weight.用于基因传递的 HPMA-寡聚赖氨酸共聚物:肽长度和聚合物分子量的优化。
J Control Release. 2011 Oct 30;155(2):303-11. doi: 10.1016/j.jconrel.2011.07.009. Epub 2011 Jul 14.